Advanced search
Publication Cover
Current Opinion on Therapeutic Patents Volume 2, 1992 - Issue 7
Journal homepage
7
Views
1
CrossRef citations to date
0
Altmetric
Antimicrobials

Patent Update: Compounds with Activity against the Herpetoviridae

Gerhard Jähne Hoechst AG, SBU Antiinfectives - Research, G838, PO Box 800320, D-6230 Frankfurt/Main 80, Germany
Pages 995-1012 | Published online: 02 Mar 2011

References to Primary Literature

  • Prusoff WH Synthesis and biological activity of iododeoxyuridine, an analog of thymidine. Biochem. Biophys. Acta 1959 32 295–296.
  • Prusoff WH Idoxuridine or how it all began. Clinical use of antiviral drugs De Clercq E Martinus Nijhoff Boston 1988, 15–24.
  • Heidelberger C, Parsons D, Remy DC Synthesis of 5-trifluoromethyluracil and 5-(trifluoromethyl)-2′-deoxyuridine. J. Am. Chem. Soc. 1962 84 3597–3598.
  • Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS Trifluridine: A review of its antiviral activity and therapeutic use in topical treatment of viral eye infections. Drugs 1982 23 329–353.
  • Lee WS, Benitez A, Goodman L, Baker BR Potential anticancer agents. XL. Synthesis of the β-anomer of 9-(D-arabinofuranosyl)-adenine. J. Am. Chem. Soc. 1960 82 2648–2649.
  • Buchanan RA, Hess F Vidarabine (Vira-A®): Pharmacology and clinical experience. Pharmacol. Ther. 1980 8 143–171.
  • Schaeffer HJ, Beauchamp C, De Miranda P, Elion GB, Bauer DJ, Collins P 9-(2-hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 1978 272 583–585.
  • Remy RJ, Secrist JA III Acyclic nucleosides other than acyclovir as potential antiviral agents. Nucleosides & Nucleotides 1985 4 411–427.
  • Chu CK, Cutler SJ Chemistry and antiviral activities of acyclonucleosides. J. Heterocyclic Chem. 1986 23 289–319.
  • Ogilvie KK, Cheriyan UO, Radatus BK, Smith KO, Galloway KS, Kennell WL Biologically active acyclonucleoside analogues. II. The synthesis of 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine(BIOLF-62). Can. J. Chem. 1982 60 3005–3010.
  • Helgstrand E, Erikkson B, Johansson NG, Lannerö B, Larsson A, Misiorny A, Norén JO, Sjöberg B, Steinberg K, Stening G, Stridh S, Öberg B Trisodium phosphonoformate, a new antiviral compound. Science 1978 201 819–821.
  • Hirsch MS, Kaplan JC Antiviral Agents. Virology Fields BN Knipe DM Chanock RM Hirsch MS Melnick JL Monath TP Roizman B Raven Press New York 1990, 441–468.
  • Crumpacker CS II Molecular targets of antiviral therapy. New Engl. J. Med. 1989 321 163–172.
  • Estes JE, Huang E-S Stimulation of cellular thymidine kinase by human cytomegalovirus. J. Virol. 1977 24 13–21.
  • Verheyden JPH Non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT). Curr. Opin. Thera. Patents 1991 1 1294–1304.
  • Dalziel W, Hesp B, Stevenson KM, Jarvis JAJ The structure and absolute configuration of the antibiotic aphidicolin: A tetracyclic diterpenoid containing a new ring system. J. Chem. Soc. Perkin Trans. I 1973, 2841–2851.
  • Huberman JA New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase α. Cell 1981 23 647–648.
  • Spector T, Harrington JA, Morrison RW, Lambe CU, Nelson DJ, Averett DR, Biron K, Furman PA 2-Acetylpyridine-5-[(dimethyl-amino)thiocarbonyl]thiocarbonohydrazone (A111OU), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella zoster viruses and a potentiator of acyclovir. Proc. Natl. Acad. Sci. USA 1989 86 1051–1055.
  • Reardon JE, Spector T Acyclovir: Mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors. Adv. Pharmacol. 1991 22 1–27.
  • Spector T, Lobe DC, Ellis MN, Blumenkopf TA, Szczech GM Inactivators of herpes simplex virus ribonucleotide reductase: Hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Antimicrob. Agents Chemother. 1992 36 934–937.
  • Liu F, Roizman B The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate. J. Virol. 1991 65 5149–5156.
  • Welch AR, Woods AS, McNally LM, Cotter RJ, Gibson W A herpesvirus maturational proteinase, assemblin: Identification of its gene, putative active site domain, and cleavage site. Proc. Natl. Acad. Sci. USA 1991 88 10792–10796.
  • Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986 234 596–601.
  • Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc. Natl. Acad. Sci. USA 1991 88 5922–5926.
  • Schneweis KE, Gelderblom H, Eis-Hübinger AM Das 6. humane Herpesvirus: Diagnostische Möglichkeiten und pathogenetische Probleme (Human herpesvirus 6: Diagnosis of infection and pathogenetic problems). Lab. Med. 1990 14 261–265.
  • Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T Identification of human herpesvirus-6 as a causal agent for exanthema subitum. Lancet 1988 ii 1065–1067.
  • Portolani M, Cermelli C, Pietrosemoli P, Pecorari M, Farabegoli F, Cavazzuti GB, Bertolani MF, Micheli A Isolation of HHV-6-related virus from children affected by infectious syndrome. Arch. Virol. 1990 110 143–149.
  • Montgomery JA, Clayton SD, Thomas HJ Isonucleosides. I. Preparation of methyl 2-deoxy-2-(purin-9-yl)arabinofuranosides and methyl 3-deoxy-3-(purin-9-yl)xylofuranosides. J. Org. Chem. 1975 40 1923–1927.
  • Montgomery JA, Thomas HJ Isonucleosides. 2. Purine and pyrimidine derivatives of 1,4-anhydro-2-deoxy-D-arabinitol. J. Org. Chem. 1978 43 541–544.
  • Lin T-S, Shen Z-Y, August EM, Brankovan V, Yang H, Ghazzouli I, Prusoff WH Synthesis and antiviral activity of several 2,5′-anhydro analogues of 3′-azido-3′ deoxythymidine, 3′-azido-2′,3′-dideoxyuridine, 3′-azido-2′,3′-dideoxy-5-halouridines, and 3′-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia virus. J. Med. Chem. 1989 32 1891–1895.
  • De Clercq E, Descamps J, Balzarini J, Gizievicz J, Barr PJ, Robins MJ Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosides. J. Med. Chem. 1983 26 661–666.
  • Norbeck DW, Sham HL, Herrin T, Rosenbrook W, Plattner JJ Synthesis of (±) Cycloprop-G, the cyclopropyl analogue of the broad spectrum antiviral agent Cyclobut-G. J. Chem. Soc. Chem. Commun. 1992, 128–129.
  • Shimada N, Hasegawa S, Harada T, Tomisawa T, Fujii A, Takita T Oxetanocin, a novel nucleoside from bacteria. J. Antibiot. 1986 39 1623–1625.
  • Nishiyama Y, Yamamoto N, Takahash K, Shimada N Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G. Antimicrob. Agents Chemother. 1988 32 1053–1056.
  • Daikoku T, Yamamoto N, Saito S, Kitagawa M, Shimada N, Nishiyama Y Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G. Biochem. Biophys. Res. Commun. 1991 176 805–812.
  • Nishiyama S, Yamamura S, Kato K, Takita T Synthetic studies on oxetanocin, a novel nucleoside with an oxetane ring. Synthesis of some chiral D-oxetanosyl acylates. Tetrahedron Lett. 1988 29 4739–4742.
  • Nishiyama S, Yamamura S, Kato K, Takita T A total synthesis of oxetanocin, a novel nucleoside with an oxetane ring. Tetrahedron Lett. 1988 29 4743–4746.
  • Field AK, Tuomari AV, McGeever-Rubin B, Terry BJ, Mazina KE, Haffey ML, Hagen ME, Clark JM, Braitman A, Slusarchyk WA, Young MG, Zahler R (±)(1α,-2β,3α)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(±)-BHCG or SQ 33054]: A potent and selective inhibitor of herpesviruses. Antiviral Res. 1990 13 41–52.
  • Blackburn GM Phosphonates as analogues of biological phosphates. Chem. & Ind. 1981, 134–138.
  • Blackburn GM, Kent DE, Kolkmann F The synthesis and metal binding characteristics of novel, isopolar phosphonate analogues of nucleosides. J. Chem. Soc. Perkin Trans. I 1984, 1119–1125.
  • Chambers RD, O'Hagan D, Lamont RB, Jain SC The difluoromethylenephosphonate moiety as a phosphate mimic: X-Ray structure of 2-amino-1,1-difluoroethylphosphonic acid. J. Chem. Soc. Chem. Commun. 1990, 1053–1054.
  • Drugs of the Future 1985 10 586–588.
  • Nishiyama Y, Yamamoto N, Takahash K, Shimada N Selective inhibition of human cytomegalovirus replication by a novel nucleoside, Oxetanocin G. Antimicrob. Agents Chemother. 1988 32 1053–1056.
  • Sakuma T, Saijo M, Suzutani T, Yoshida I, Saito S, Kitagawa M, Hasegawa S, Azuma M Antiviral activity of oxetanocins against varicella-zoster virus. Antimicrob. Agents Chemother. 1991 35 1512–1514.
  • Slusarchyk WA, Bisacchi GS, Hockstein DR, Young MG, Field AK, McGeever-Rubin B, Tuomari AV, Zahler R SQ-33,054: A potent member of a new class of nucleosideanalog antivirals. XXIX Inter-science Conference on Antimicrobial Agents and Chemotherapy Houston 1989 Abstract #1330.
  • Harnden MR, Parkin A, Wyatt PG Synthesis of 9-(3-hydroxy propoxy)guanine, a novel antiviral acyclonucleoside. Tetrahedron Lett. 1988 29 701–704.
  • Harnden MR, Jennings LJ, Parkin A Synthesis of 1-(hydroxyalkoxy)pyrimidines, a novel series of acyclic nucleoside analogues. Tetrahedron Lett. 1988 29 4013–4016.
  • De Clercq E, Holý A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC A novel selective broad-spectrum anti-DNA virus agent. Nature 1986 323 464–467.
  • Megati S, Phadtare S, Zemlicka J Unsaturated phosphonates as acyclic nucleotide analogues. Anomalous Michaelis Arbuzov and Michaelis-Becker reactions with multiple bond systems. J. Org. Chem. 1992 57 2320–2327.
  • Holý A, Rosenberg I Phosphonylalkoxyalkyl and phosphonylalkyl derivatives of heterocyclic bases. Nucleosides & Nucleotides 1989 8 673–688.
  • Holý A, Votruba I, Merta A, Cerný J, Veselý J, Vlach J, Sediva K, Rosenberg I, Otmar M, Hrebabecký H, Trávnícek M, Vonka V, Snoeck R, De Clercq E Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus encoded enzymes in vitro.. Antiviral Res. 1990 13 295–312.
  • Winkler I, Winkelmann E, Scholl T, Rösner M, Jähne G, Helsberg M Antiviral activity and phamacokinetics of HOE 602, an acyclic nucleoside, in animal models. Antiviral Res. 1990 14 61–73.
  • Winkler I, Helsberg M, Scholl T, Meichsner C, Jähne G, Rösner M Antiviral activity and metabolism of 7-isomer derivatives of the purine nucleoside analogue HOE 602. Antiviral Res. (Suppl. I) 1990 Abstract #31.
  • Helsberg M, Jähne G, Rösner M, Scholl T, Winkler I Antiviral activity of acyclic 7-isomers of purine nucleoside derivatives. VIIIth International Congress of Virology Berlin 1990, 34–022.
  • Goldstein DJ, Weller SK Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensible for virus growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 1988 62 196–205.
  • Cameron JM, McDougall I, Marsden HS, Preston VG, Ryan DM, Subak-Sharpe JH Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 1988 69 2607–2612.
  • Dutia BM, Frame MC, Subak-Sharpe JH, Clark WN, Marsden DH Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature 1986 321 439–441.
  • Cohen EA, Gaudreau P, Brazeau P, Langelier Y Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature 1986 321 441–443.
  • Zamecnik PC, Stephenson M Inhibition of Rous sarkoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 1978 75 280–284.
  • Uhlmann E, Peyman A Antisense oligonucleotides: A new therapeutic principle. Chem. Rev. 1990 90 543–584.
  • Cohen JS Oligonucleotides as therapeutic agents. Pharmac. Ther. 1991 52 211–225.
  • Look SA, Fenical W, Matsumoto GK, Clardy J The pseudopterosins: A new class of antiinflammatory and analgesic diterpene pentosides from the marine sea whip Pseudopterogorgia elisabethae (Octocorallia). J. Org. Chem. 1986 51 5140–5145.
  • Drugs of the Future 1988 13 673–674.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.